Condition
Ketones
Total Trials
6
Recruiting
2
Active
2
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
17%
1 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
6Total
Not Applicable (2)
P 1 (1)
P 2 (2)
P 4 (1)
Trial Status
Completed3
Recruiting2
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 3 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT07325201Phase 2Not Yet Recruiting
Mitigating DKA in Type 1 Diabetes for Safe Use of SGLT Inhibitors Using Dual Continuous Ketone and Glucose Monitoring.
NCT06327464Not ApplicableCompleted
Exogenous Ketones and Appetite
NCT07527156Phase 4Recruiting
Prolonged Nasogastric Administration of Ketones in Decompensated Heart Failure
NCT07186660Phase 2Recruiting
Evaluation of a Novel Insulin Sensitizer in People With Type 1 Diabetes
NCT03461068Phase 1CompletedPrimary
Exogenous Ketones and Glucose Tolerance
NCT02825823Not ApplicableCompleted
The Effects of Exogenous Ketones on Exercise Performance in Young Healthy Adults
Showing all 6 trials